000 01132 a2200313 4500
005 20250517081737.0
264 0 _c20180608
008 201806s 0 0 eng d
022 _a1468-2060
024 7 _a10.1136/annrheumdis-2016-209300
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCornec, Divi
245 0 0 _aDo high numbers of salivary gland-infiltrating B cells predict better or worse outcomes after rituximab in patients with primary Sjögren's syndrome?
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_c06 2016
300 _ae33 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aB-Lymphocytes
650 0 4 _aHumans
650 0 4 _aRituximab
650 0 4 _aSalivary Glands
650 0 4 _aSjogren's Syndrome
700 1 _aCosta, Sebastian
700 1 _aDevauchelle-Pensec, Valérie
700 1 _aChiche, Laurent
700 1 _aSaraux, Alain
700 1 _aPers, Jacques-Olivier
773 0 _tAnnals of the rheumatic diseases
_gvol. 75
_gno. 6
_gp. e33
856 4 0 _uhttps://doi.org/10.1136/annrheumdis-2016-209300
_zAvailable from publisher's website
999 _c25751086
_d25751086